Advanced Search

CN 34-1304/RISSN 1674-3679

Volume 23 Issue 3
Mar.  2019
Turn off MathJax
Article Contents
ZHOU Xiao-yan, ZHAO Qi, WANG Na, WANG Rui-ping, ZHANG Yue, YU Yu-ting, JIANG Yong-gen, ZHAO Gen-ming. Relationship between hyperuricemia and chronic kidney disease in adult residents of communities in the Songjiang district, Shanghai[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2019, 23(3): 278-282, 293. doi: 10.16462/j.cnki.zhjbkz.2019.03.007
Citation: ZHOU Xiao-yan, ZHAO Qi, WANG Na, WANG Rui-ping, ZHANG Yue, YU Yu-ting, JIANG Yong-gen, ZHAO Gen-ming. Relationship between hyperuricemia and chronic kidney disease in adult residents of communities in the Songjiang district, Shanghai[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2019, 23(3): 278-282, 293. doi: 10.16462/j.cnki.zhjbkz.2019.03.007

Relationship between hyperuricemia and chronic kidney disease in adult residents of communities in the Songjiang district, Shanghai

doi: 10.16462/j.cnki.zhjbkz.2019.03.007
  • Received Date: 2018-09-13
  • Rev Recd Date: 2018-11-23
  • Publish Date: 2019-03-10
  •   Objective  To explore the relationships between hyperuricemia (HUA), serum uric acid (SUA) level and the chronic kidney disease (CKD) in adult residents of communities.  Methods  A cross-sectional study was conducted in Xinqiao town of Songjiang district, Shanghai and a total of 9 527 residents aged 20-75 years were selected by random cluster sampling. Logistic regression models were used to evaluate the association between SUA and CKD.  Results  Subjects were divided into five groups according to the gender-specific quintiles of SUA. The CKD prevalence in serum uric acid quintiles of male were 4.9%, 5.7%, 6.0%, 8.0% and 13.8% respectively, while of female were 12.8%, 12.7%, 11.9%, 13.3% and 18.2% respectively, increasing along with the increase of SUA among both sexes (all P<0.05). Compared to the serum uric acid first quintile, the multivariate-adjusted odds for CKD in male of the fourth and fifth quintiles were 2.12 (95% CI: 1.32-3.39) and 3.84 (95% CI: 2.45-6.02), and the multivariate-adjusted odds for CKD in female of the fifth quintile was 1.38 (95% CI: 1.05-1.80). Hyperuricemia was defined by SUA>420 μmol/L(male) or >360 μmol/L(female). In the unadjusted model, HUA was significantly associated with CKD of all subjects (OR=2.03, 95% CI: 1.69-2.44, P<0.001), and the association was still significant (OR=2.04, 95% CI: 1.68-2.49, P<0.001) after adjustment for the potential confounders. The multivariate-adjusted odds of CKD associated with HUA was 2.89 (95% CI: 2.12-3.94, ) and 1.98 (95% CI: 1.51-2.60) for male and female, respectively.  Conclusion  Hyperuricemia was independently associated with the increased prevalence of CKD among community-based population living in the Songjiang district, Shanghai.
  • loading
  • [1]
    Coresh J. Update on the Burden of CKD[J]. Journal of the American Society of Nephrology, 2017, 28(4): 1020-1022. DOI: 10.1681/ASN.2016121374.
    [2]
    Gibson T. Hyperuricemia, gout and the kidney[J]. Curr Opin Rheumatol, 2012, 24(2): 127-131. DOI: 10.1097/BOR.0b013e32834f049f.
    [3]
    Hsu CY, Iribarren C, McCulloch CE, et al. Risk factors for end-stage renal disease: 25-year follow-up[J]. Arch Intern Med, 2009, 169(4): 342-350. DOI: 10.1001/archinternmed.2008.605.
    [4]
    Johnson RJ, Nakagawa T, Jalal D, et al. Uric acid and chronic kidney disease: which is chasing which?[J]. Nephrol Dial Transplant, 2013, 28(9): 2221-2228. DOI: 10.1093/ndt/gft029.
    [5]
    Feig DI. Uric acid: a novel mediator and marker of risk in chronic kidney disease?[J]. Curr Opin Nephrol Hypertens, 2009, 18(6): 526-530. DOI: 10.1097/MNH.0b013e328330d9d0.
    [6]
    Chou YC, Kuan JC, Yang T, et al. Elevated uric acid level as a significant predictor of chronic kidney disease: a cohort study with repeated measurements[J]. J Nephrol, 2015, 28(4): 457-462. DOI: 10.1007/s40620-014-0158-9.
    [7]
    Krishnan E, Akhras KS, Sharma H, et al. Serum urate and incidence of kidney disease among veterans with gout[J]. J Rheumatol, 2013, 40(7): 1166-1172. DOI: 10.3899/jrheum.121061.
    [8]
    Sedaghat S, Hoorn EJ, van Rooij FJ, et al. Serum uric acid and chronic kidney disease: the role of hypertension[J]. PLoS One, 2013, 8(11): e76827. DOI: 10.1371/journal.pone.0076827.
    [9]
    Mok Y, Lee SJ, Kim MS, et al. Serum uric acid and chronic kidney disease: the Severance cohort study[J]. Nephrol Dial Transplant, 2012, 27(5): 1831-1835. DOI: 10.1093/ndt/gfr530.
    [10]
    周弋, 齐慧, 赵根明, 等. 上海市浦东新区居民高尿酸血症与慢性肾病相关性研究[J]. 中华流行病学杂志, 2012, 33(4): 351-355. DOI: 10.3760/cma.j.issn.0254-6450.2012.04.001.

    Zhou Y, Qi H, Zhao GM, et al. Relationship between hvperuricemia and chronic kidney disease in Pudong New Area of Shanghai[J]. Chin J Epidemiol, 2012, 33(4): 351-355. DOI: 10.3760/cma.j.issn.0254-6450.2012.04.001.
    [11]
    Yamada T, Fukatsu M, Suzuki S, et al. Elevated serum uric acid predicts chronic kidney disease[J]. Am J Med Sci, 2011, 342(6): 461-466. DOI: 10.1097/MAJ.0b013e318218bd89.
    [12]
    Wang S, Shu Z, Tao Q, et al. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan[J]. Nephrology(Carlton), 2011, 16(8): 767-776. DOI: 10.1111/j.1440-1797.2011.01513.x.
    [13]
    Bellomo G, Venanzi S, Verdura C, et al. Association of uric acid with change in kidney function in healthy normotensive individuals[J]. Am J Kidney Dis, 2010, 56(2): 264-272. DOI: 10.1053/j.ajkd.2010.01.019.
    [14]
    Kuriyama S, Maruyama Y, Nishio S, et al. Serum uric acid and the incidence of CKD and hypertension[J]. Clin Exp Nephrol, 2015, 19(6): 1127-1134. DOI: 10.1007/s10157-015-1120-4.
    [15]
    邹贵勉, 黄江燕, 车文体, 等. 广西城市社区居民高尿酸血症流行病学调查及其与慢性肾脏病的关系[J]. 中华内分泌代谢杂志, 2011, 27(7): 561-565. DOI: 10.3760/cma.j.issn.1000-6699.2011.07.005.

    Zou GM, Huang JY, Che WT, et al. An epidemiological study on the prevalence of hyperuricemia and its relationship to chronic kidney disease in the urban community residents of Guangxi[J]. Chin J Endocrinol Metab, 2011, 27(7): 561-565. DOI: 10.3760/cma.j.issn.1000-6699.2011.07.005
    [16]
    全国eGFR课题协作组. MDRD方程在我国慢性肾脏病患者中的改良和评估[J]. 中华肾脏病杂志, 2006, 22(10): 589-595. DOI: 10.3760/j.issn:1001-7097.2006.10.002.

    Chinese eGFR Investigation Collaboration. Modification and evaluation of MDRD estimating equation for Chinese patients with chronic kidney disease[J]. Chin J Nephrol, 2006, 22(10): 589-595. DOI: 10.3760/j.issn:1001-7097.2006.10.002.
    [17]
    K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Am J Kidney Dis, 2002, 39(2 Suppl 1): S1-S266
    [18]
    中华医学会内分泌学分会. 高尿酸血症和痛风治疗的中国专家共识[J]. 中华内分泌代谢杂志, 2013, 29(11): 913-920. DOI: 10.3760/cma.j.issn.1000-6699.2013.11.001.

    Endocrine committee of Chinese Medical Association. Chinese expert consensus on hyperuricemia and gout treatment[J]. Chin J Endocrinol Metab, 2013, 29(11): 913-920. DOI: 10.3760/cma.j.issn.1000-6699.2013.11.001.
    [19]
    Ren P, Gao M. Association Between Metabolic Syndrome and the Serum Uric Acid: a Cohort Study[J]. Clin Lab, 2018, 64(5): 719-726. DOI:10.7754/Clin.Lab, 2017.171037.
    [20]
    Abbasian M, Ebrahimi H, Delvarianzadeh M, et al. Association between serum uric acid (SUA) levels and metabolic syndrome (MetS) components in personnel of Shahroud University of Medical Sciences[J]. Diabetes Metab Syndr, 2016, 10(3): 132-136. DOI: 10.1016/j.dsx.2016.01.003.
    [21]
    Babio N, Martinez-Gonzalez MA, Estruch R, et al. Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study[J]. Nutr Metab Cardiovasc Dis, 2015, 25(23): 173-180. DOI: 10.1016/j.numecd.2014.10.006.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Article Metrics

    Article views (267) PDF downloads(35) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return